Jose R. Conejo-Garcia Tumor Microenvironment and Metastasis Program Wistar Institute Biography Publications Institution JoVE Articles Jose R. Conejo-Garcia has not added a biography. If you are Jose R. Conejo-Garcia and would like to personalize this page please email our Author Liaison for assistance. Publications Local Hyperthermia Treatment of Tumors Induces CD8(+) T Cell-mediated Resistance Against Distal and Secondary Tumors Nanomedicine : Nanotechnology, Biology, and Medicine. Feb, 2014 | Pubmed ID: 24566274 A Role for the Chemokine Receptor CCR6 in Mammalian Sperm Motility and Chemotaxis Journal of Cellular Physiology. Jan, 2014 | Pubmed ID: 23765988 Pathological Mobilization and Activities of Dendritic Cells in Tumor-Bearing Hosts: Challenges and Opportunities for Immunotherapy of Cancer Frontiers in Immunology. 2013 | Pubmed ID: 24339824 Three-dimensional Culture Sensitizes Epithelial Ovarian Cancer Cells to EZH2 Methyltransferase Inhibition Cell Cycle (Georgetown, Tex.). Jul, 2013 | Pubmed ID: 23759589 Avirulente Toxoplasma Gondii Génère L'immunité Antitumorale Thérapeutiques Par Inversion De L'Immunosuppression Dans Le Microenvironnement De Cancer Ovarien Cancer Research. Jul, 2013 | Pubmed ID: 23704211 Phagocytes Mediate Targeting of Iron Oxide Nanoparticles to Tumors for Cancer Therapy Integrative Biology : Quantitative Biosciences from Nano to Macro. Jan, 2013 | Pubmed ID: 22935885 Modulating the Tumor Immune Microenvironment As an Ovarian Cancer Treatment Strategy Expert Review of Obstetrics & Gynecology. Sep, 2012 | Pubmed ID: 24039628 Good Things Come in Small Packages: Therapeutic Anti-tumor Immunity Induced by MicroRNA Nanoparticles Oncoimmunology. Sep, 2012 | Pubmed ID: 23162774 Anti-tumor Immunity: Myeloid Leukocytes Control the Immune Landscape Cellular Immunology. Jul-Aug, 2012 | Pubmed ID: 23121972 Editorial: A Clear Vision Needs Some Balance Journal of Leukocyte Biology. Nov, 2012 | Pubmed ID: 23118443 Does the F508-CFTR Mutation Induce a Proinflammatory Response in Human Airway Epithelial Cells? American Journal of Physiology. Lung Cellular and Molecular Physiology. Sep, 2012 | Pubmed ID: 22821996 Mast Cells Impair the Development of Protective Anti-tumor Immunity Cancer Immunology, Immunotherapy : CII. Dec, 2012 | Pubmed ID: 22684520 Double Agents in the War on Cancer: Leukocytes Govern Ovarian Cancer Progression Oncotarget. Mar, 2012 | Pubmed ID: 22538964 Ovarian Cancer Progression is Controlled by Phenotypic Changes in Dendritic Cells The Journal of Experimental Medicine. Mar, 2012 | Pubmed ID: 22351930 Reprogramming Tumor-associated Dendritic Cells in Vivo Using MiRNA Mimetics Triggers Protective Immunity Against Ovarian Cancer Cancer Research. Apr, 2012 | Pubmed ID: 22307839 It Never Rains but It Pours: Potential Role of Butyrophilins in Inhibiting Anti-tumor Immune Responses Cell Cycle (Georgetown, Tex.). Feb, 2011 | Pubmed ID: 21270530 CD277 is a Negative Co-stimulatory Molecule Universally Expressed by Ovarian Cancer Microenvironmental Cells Oncotarget. Sep, 2010 | Pubmed ID: 21113407 Harnessing the Effect of Adoptively Transferred Tumor-reactive T Cells on Endogenous (host-derived) Antitumor Immunity Clinical & Developmental Immunology. 2010 | Pubmed ID: 21076522 Fluorescence-based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2010 | Pubmed ID: 20682703 CD4+ T Cells Elicit Host Immune Responses to MHC Class II-negative Ovarian Cancer Through CCL5 Secretion and CD40-mediated Licensing of Dendritic Cells Journal of Immunology (Baltimore, Md. : 1950). May, 2010 | Pubmed ID: 20400704 Mycobacterium Tuberculosis Infection Induces Il12rb1 Splicing to Generate a Novel IL-12Rbeta1 Isoform That Enhances DC Migration The Journal of Experimental Medicine. Mar, 2010 | Pubmed ID: 20212068 Blocking Ovarian Cancer Progression by Targeting Tumor Microenvironmental Leukocytes Cell Cycle (Georgetown, Tex.). Jan, 2010 | Pubmed ID: 20023378 Nanomolecular Targeting of Dendritic Cells for Ovarian Cancer Therapy Future Oncology (London, England). Oct, 2009 | Pubmed ID: 19852731 In Situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells Cancer Research. Sep, 2009 | Pubmed ID: 19738057 Polyethylenimine-based SiRNA Nanocomplexes Reprogram Tumor-associated Dendritic Cells Via TLR5 to Elicit Therapeutic Antitumor Immunity The Journal of Clinical Investigation. Aug, 2009 | Pubmed ID: 19620771 CCL5-mediated Endogenous Antitumor Immunity Elicited by Adoptively Transferred Lymphocytes and Dendritic Cell Depletion Cancer Research. Aug, 2009 | Pubmed ID: 19602595 Identifying Alemtuzumab As an Anti-myeloid Cell Antiangiogenic Therapy for the Treatment of Ovarian Cancer Journal of Translational Medicine. 2009 | Pubmed ID: 19545375 L'épuisement Des Retards Cellules Ovariennes Progression Du Cancer Dendritiques Par Stimuler L'immunité Antitumorale Cancer Research. Sep, 2008 | Pubmed ID: 18768667 PILAR is a Novel Modulator of Human T-cell Expansion Blood. Aug, 2008 | Pubmed ID: 18550855 Role of Vascular Leukocytes in Ovarian Cancer Neovascularization Advances in Experimental Medicine and Biology. 2008 | Pubmed ID: 18546635 Scavenger Receptor-A-targeted Leukocyte Depletion Inhibits Peritoneal Ovarian Tumor Progression Cancer Research. May, 2007 | Pubmed ID: 17510407 Leucocytes Vasculaires: Une Population Avec Des Propriétés Angiogéniques Et Immunossuppressive Fortement Représentés Dans Le Cancer De L'ovaire Advances in Experimental Medicine and Biology. 2007 | Pubmed ID: 17191386 La Vaccination Directe Avec Des Cellules Tumorales Tuées Avec ICP4-déficient HSVd120 Déclenche Une Immunité Anti-tumorale Efficace Cancer Biology & Therapy. Jul, 2006 | Pubmed ID: 16861891 L'utilisation De L'immuno-LCM Pour Identifier Le Profil D'expression Dans Le in Situ Des Constituants Cellulaires Du Microenvironnement Tumoral Cancer Biology & Therapy. Jun, 2006 | Pubmed ID: 16627987 Immunotherapy for Gynaecological Malignancies Expert Opinion on Biological Therapy. Sep, 2005 | Pubmed ID: 16120050 Oncolytic HSV Exerce Direct Activité Anti-angiogénique Dans Les Cancers De L'ovaire Human Gene Therapy. Jun, 2005 | Pubmed ID: 15960607 HSV Oncolytique Thérapie Régule à La Hausse L'interféron-inductibles Chimiokines Et De Recrues Des Cellules Immunitaires Effectrices En Cancer Des Ovaires Molecular Therapy : the Journal of the American Society of Gene Therapy. Nov, 2005 | Pubmed ID: 15925544 Leucocytes Vasculaires Contribuer à La Vascularisation Tumorale Blood. Jan, 2005 | Pubmed ID: 15358628 Infiltrant Les Tumeurs Précurseurs De Cellules Dendritiques Recrutées Par Un Bêta-défensines Contribuer à Vasculogenèse Sous L'influence De VEGF-A Nature Medicine. Sep, 2004 | Pubmed ID: 15334073 Recrutement Spécifique De Cellules T Régulatrices Dans Le Carcinome Ovarien Fosters Privilège Immunitaire Et Prédit Une Survie Réduite Nature Medicine. Sep, 2004 | Pubmed ID: 15322536 Cancer De L'ovaire Exprime L'Letal Ligand NKG2D Et Favorise La Survie Et L'expansion Des Cellules T CD28-antitumoraux Cancer Research. Mar, 2004 | Pubmed ID: 15026360 Letal, Un Ligand Associé à Une Tumeur Immunorécepteur NKG2D, Induit L'activation Et L'expansion De Cellules Immunitaires Effectrices Cancer Biology & Therapy. Jul-Aug, 2003 | Pubmed ID: 14508119 Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer The New England Journal of Medicine. Jan, 2003 | Pubmed ID: 12529460 Initiation de carcinome du sein métastatique en ciblant de l'épithélium canalaire avec adénovirus Cre: un modèle de souris transgénique roman du cancer du sein Melanie R. Rutkowski*1, Michael J. Allegrezza*1, Nikolaos Svoronos1, Amelia J. Tesone1, Tom L. Stephen1, Alfredo Perales-Puchalt1, Jenny Nguyen1, Paul J. Zhang2, Steven N. Fiering3, Julia Tchou4,5,6, Jose R. Conejo-Garcia1 1Tumor Microenvironment and Metastasis Program, Wistar Institute, 2Department of Pathology and Lab Medicine, Perelman School of Medicine, University of Pennsylvania, 3Department of Microbiology and Immunology and Department of Genetics, Geisel School of Medicine at Dartmouth, 4Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 5Rena Rowan Breast Center, Abramson Cancer Center, University of Pennsylvania, 6Center for Advanced Medicine, University of Pennsylvania JoVE 51171 Medicine
Initiation de carcinome du sein métastatique en ciblant de l'épithélium canalaire avec adénovirus Cre: un modèle de souris transgénique roman du cancer du sein Melanie R. Rutkowski*1, Michael J. Allegrezza*1, Nikolaos Svoronos1, Amelia J. Tesone1, Tom L. Stephen1, Alfredo Perales-Puchalt1, Jenny Nguyen1, Paul J. Zhang2, Steven N. Fiering3, Julia Tchou4,5,6, Jose R. Conejo-Garcia1 1Tumor Microenvironment and Metastasis Program, Wistar Institute, 2Department of Pathology and Lab Medicine, Perelman School of Medicine, University of Pennsylvania, 3Department of Microbiology and Immunology and Department of Genetics, Geisel School of Medicine at Dartmouth, 4Division of Endocrine and Oncologic Surgery, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, 5Rena Rowan Breast Center, Abramson Cancer Center, University of Pennsylvania, 6Center for Advanced Medicine, University of Pennsylvania JoVE 51171 Medicine